Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • CORRESPONDENCE

Equitable drug access: small-scale manufacturing units can help

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Nature 609, 245 (2022)

doi: https://doi.org/10.1038/d41586-022-02803-8

Competing Interests

K.R.L. is an owner, shareholder and employee of Sunflower Therapeutics PBC. Ameer Basrai is an employee and shareholder of Roivant Sciences. Anthony Bogachev is an employee of Roivant Social Ventures and a shareholder of Rovant Sciences. F.R. is a consultant for the Bill & Melinda Gates Foundation and a member of the board of directors of VaxThera, a Sura Company.

Subjects

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Quick links